# LLM Judge Evaluation: tier1_007

## Overall: FAIL

### Scores:
- **Completion**: 0/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 0/6

### Reasoning:
Completion: The trace shows only two molecule_lookup calls that returned the strings “semaglutide” and “910463-68-2” without any structure. No pKa workflow was actually submitted or completed, and no numerical pKa was reported. Despite the “Completion Status: Completed” claim, the core computation never ran; therefore, no result to interpret.

Correctness: Because no numerical pKa was produced, there is nothing to compare against literature. To be thorough, I located literature/predicted reference values for semaglutide’s basic sites (DrugBank/Chemaxon strongest basic pKa and canonical residue model pKa values), but absolute/percent error cannot be computed relative to a missing agent value.

Tool Use: The agent selected a lookup tool but failed to retrieve a computable structure (SMILES/SDF) and did not pivot to alternative sources (PubChem/DrugBank/ChEMBL) that do provide structures and predicted micro-pKa values. No validation step or pKa job submission occurred. Asking the user for a structure and clarifying “which amine” was reasonable, but claiming completion without running the workflow is a process failure.

### Feedback:
- You did not complete the pKa computation. Retrieve a structure (e.g., SMILES/SDF) from DrugBank or PubChem and then run a site-specific microscopic pKa workflow.
- Disambiguate the target site upfront: N-terminal α-amine vs. the free lysine ε-amine (the acylated lysine is no longer basic). Report site assignments clearly.
- As a fallback, cite predicted values if computation fails: DrugBank lists semaglutide’s strongest basic pKa (12.26), and canonical peptide pKa values place Lys ε-NH3+ near 10.4–10.5 and N-terminus near ~8.0. Use these to sanity-check computed results. ([go.drugbank.com](https://go.drugbank.com/drugs/DB13928))
- Literature validation: 1) Agent’s computed value: None reported (no pKa returned).

2) Literature/predicted values (for context):
- Semaglutide predicted strongest basic pKa = 12.26 (Chemaxon “Predicted Properties” on DrugBank DB13928). This likely corresponds to a guanidinium (Arg) site, not an amine. ([go.drugbank.com](https://go.drugbank.com/drugs/DB13928))
- Model pKa values for amino groups in peptides/proteins:
  • Lys ε-NH3+ side chain: ~10.4–10.5. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai))
  • N-terminal α-amine: ~8.0. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai))
  • Arg guanidinium: ~13.5 (protein studies) and ~13.8 ± 0.1 (solution). ([en.wikipedia.org](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai))

3) Absolute error: Not applicable (no agent value).

4) Percent error: Not applicable (no agent value).

5) Score justification: No computed pKa to validate; therefore, correctness scored 0. Literature/predicted references are provided only to show what should have been compared against once a value was produced.

### Web Search Citations:
1. [Semaglutide: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB13928)
2. [Protein pKa calculations](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai)
3. [Protein pKa calculations](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai)
4. [Protein pKa calculations](https://en.wikipedia.org/wiki/Protein_pKa_calculations?utm_source=openai)
5. [Semaglutide: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB13928)

### Execution:
- **Tools**: molecule_lookup
- **Time**: 1.2 min

---
*Evaluated with openai/gpt-5*
